- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
New Payment Model Aims to Reduce Cardiovascular Risk
A new payment model through the Affordable Care Act seeks to decrease cardiovascular disease for tens of thousands of Medicare beneficiaries by assessing patient risks for heart attack and stroke and then helping them to reduce those risks.
A new payment model through the Affordable Care Act seeks to decrease cardiovascular disease for tens of thousands of Medicare beneficiaries by assessing patient risks for heart attack and stroke and then helping them to reduce those risks.
HHS Secretary Sylvia Mathews Burwell announced the Million Hearts Cardiovascular Disease Risk Reduction model and explained that it will use a data-driven modeling approach to generate personalized risk scores and modification plans for patients. Participating providers will work to determine Medicare patients' individual risk for heart attack or stroke in the next 10 years, and identify the best approaches to reduce that risk, such as stopping smoking, reducing blood pressure, or taking cholesterol-lowering drugs or aspirin.
“The Million Hearts initiative is a part of our efforts to promote better care and smarter practices in our healthcare system,” Secretary Burwell said in a statement. “It recognizes that giving doctors more one-on-one time with their patients to prevent illness leads to better outcomes, and that greater access to health information helps empower patients to be active participants in their care.”
Providers will be paid for reducing absolute risk the absolute risk among their high-risk patients. CMS is now accepting applications for the Million Hearts Cardiovascular Disease Risk Reduction model.
Learn more at CMS: http://1.usa.gov/1G3wK38
Semaglutide Linked to Cardiovascular Gains, but Also Higher Health Spending
August 8th 2025A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and cholesterol, but also a $80 monthly rise in health care spending outside of drug costs.
Read More
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
LLMs Show Promise, but Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
